China SXT Pharmaceuticals (SXTC) Liabilities and Shareholders Equity (2018 - 2026)
China SXT Pharmaceuticals (SXTC) reported Liabilities and Shareholders Equity of $34.75 million for fiscal Q4 2026 (quarter ended Mar 31, 2026), up 60.4% from $21.66 million a year earlier.
China SXT Pharmaceuticals (SXTC) Liabilities and Shareholders Equity (2018 - 2026) Analysis & Trends
Dating back to fiscal Q4 2018, China SXT Pharmaceuticals' Liabilities and Shareholders Equity record includes 17 quarters.
- Liabilities and Shareholders Equity has a five-year compound annual growth rate of 0.1% (FY2021 to FY2026).
- By fiscal year, Liabilities and Shareholders Equity came in at $21.66 million in FY2025 (-6.3%), $23.13 million in FY2024 (-21.7%), $29.55 million in FY2023 (-11.9%) and $33.55 million in FY2022 (-2.9%).
- The fiscal Q4 2026 figure ranks as the highest quarterly Liabilities and Shareholders Equity in data going back to fiscal Q4 2018.
- Year over year, Liabilities and Shareholders Equity gained in two of the last four quarters, with growth averaging 37.9%.
- The high point for year-over-year Liabilities and Shareholders Equity in five years was fiscal Q2 2025 (growth of 112.5%); the low point was fiscal Q2 2024 (a decline of 34.2%).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | China SXT Pharmaceuticals | 39,500.23 | -85.91 Mn | - | 34.75 Mn |
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 34.75 Mn |
| Sep 30, 2025 | 26.35 Mn |
| Mar 31, 2025 | 21.66 Mn |
| Sep 30, 2024 | 31.00 Mn |
| Mar 31, 2024 | 23.13 Mn |
| Sep 30, 2023 | 14.59 Mn |
| Mar 31, 2023 | 29.55 Mn |
| Sep 30, 2022 | 22.18 Mn |
| Mar 31, 2022 | 33.55 Mn |
| Sep 30, 2021 | 22.67 Mn |
| Mar 31, 2021 | 34.55 Mn |
| Sep 30, 2020 | 24.04 Mn |
| Mar 31, 2020 | 21.70 Mn |
| Sep 30, 2019 | 23.05 Mn |
| Mar 31, 2019 | 17.47 Mn |
| Sep 30, 2018 | 7.95 Mn |
| Mar 31, 2018 | 7.66 Mn |
China SXT Pharmaceuticals Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=SXTC&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "SXTC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=SXTC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();